Related Experiment Video
Updated: Mar 31, 2026

07:31
Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
Published on: May 26, 2023
6.4K
[Requirements for organ-specific oncology centers]
1Bereichsleitung Zertifizierung, Deutsche Krebsgesellschaft e.V., Kuno-Fischer-Straße 8, 14057, Berlin, Deutschland. wesselmann@krebsgesellschaft.de.
Der Urologe. Ausg. A
|October 17, 2015
Summary
Certification of prostate cancer centers requires network cooperation. Quality indicators ensure high standards of care and treatment, improving patient outcomes through continuous assessment.
Area of Science:
- Oncology
- Healthcare Management
- Quality Improvement
Background:
- Prostate cancer center certification necessitates interdisciplinary, interprofessional, and transsectoral cooperation within a network.
- The network must encompass all disease phases from a patient-centered perspective.
- Annual audits of quality indicators by network partners ensure consistent quality of care.
Purpose of the Study:
- To outline the essential components of a prostate cancer center certification system.
- To highlight the role of quality indicators in maintaining and improving oncological care standards.
- To emphasize the network's function in reflecting comprehensive patient care pathways.
Main Methods:
- Implementation of a quality indicator system for annual auditing.
- Evaluation of quality indicator results through individual and general reports.
- Future integration of patient-reported outcomes with the OncoBox system.
Main Results:
- Quality indicators assess network cooperation, adherence to evidence-based guidelines, and partner expertise.
- The quality indicator system serves as a vital tool for quality management in daily oncological practice.
- Annual evaluations provide data for continuous improvement of prostate cancer care.
Conclusions:
- The certification system, through ongoing quantitative and qualitative enhancements, is a valuable tool for health policy.
- The system supports political discourse on quality assurance and improvement in healthcare.
- The continuous improvement cycle ensures the relevance and effectiveness of the certification process.
Related Concept Videos
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers
1.5K
1.5K
Targeted Cancer Therapies
1.8K
1.8K

